Critical Care Explorations (Jan 2023)

Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network

  • Rachel M. Belcher, PharmD, BCCCP,
  • Anastasia Blair, PharmD, BCCCP,
  • Stephanie Chauv, PharmD, BCCCP,
  • Quang Hoang, PharmD, BCCCP,
  • Abby W. Hickman, PharmD, MBA, BCCCP,
  • Melissa Peng, PharmD, BCPS,
  • Margaret Baldwin, PharmD, BCPS,
  • Logan Koch, PharmD, BCCCP,
  • Mark Nguyen, PharmD,
  • David Guidry, MD,
  • Gabriel V. Fontaine, PharmD, MBA, BCCCP, BCPS

DOI
https://doi.org/10.1097/CCE.0000000000000839
Journal volume & issue
Vol. 5, no. 1
p. e0839

Abstract

Read online

IMPORTANCE:. Critical care pharmacists when incorporated into the ICU team, have been shown to improve outcomes in critically ill patients by decreasing mortality, improving morbidity and reducing cost. As telehealth continues to evolve, the incorporation of a critical care pharmacist into a comprehensive telecritical care (TCC) service will allow increased comprehensive pharmacotherapeutic care for those in smaller, community or rural hospitals. OBJECTIVES:. To describe the implementation of a TCC pharmacist into an established TCC network, classify interventions performed, and quantify cost avoidance generated through pharmacist interventions. DESIGN:. Multicenter, observational cohort study and retrospective return on investment, performed between December 2019 and December 2021. SETTING AND PARTICIPANTS:. Critically ill adult patients, admitted to an ICU located in any of our eight community hospitals (50 ICU beds) within a large, 25-hospital integrated healthcare system (563 ICU beds total) in the United States. MAIN OUTCOMES AND MEASURES:. The TCC pharmacist service was implemented in 8-hour shifts, initially available 5 days per week, then expanded to 7 days per week. Critical care pharmacist interventions were categorized by clinical type established utilizing American Society of Health-System Pharmacists benchmarking standards and the latest cost avoidance data. RESULTS:. During the 2-year analysis period, TCC pharmacists documented 2,838 interventions generating $1,664,254 of gross cost avoidance and a return on investment of 4.5:1. CONCLUSIONS AND RELEVANCE:. It is feasible to implement a TCC pharmacist within an established TCC network. Our experience showed enhanced comprehensive care of critically ill patients located in community hospitals within a large, integrated healthcare system, demonstrated significant cost avoidance, and has led to other initiatives, including a collaborative clinical/operational partnership with Life Flight.